Press coverage about Inovalon Holdings (NASDAQ:INOV) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Inovalon Holdings earned a media sentiment score of 0.21 on Accern’s scale. Accern also gave news stories about the technology company an impact score of 0 out of 100, meaning that recent media coverage is extremely unlikely to have an impact on the stock’s share price in the near term.
Inovalon Holdings (NASDAQ INOV) remained flat at $12.85 during midday trading on Thursday. The company’s stock had a trading volume of 771,201 shares. Inovalon Holdings has a 12 month low of $8.60 and a 12 month high of $20.05. The stock has a market cap of $1.88 billion, a PE ratio of 70.99 and a beta of 1.20. The company’s 50 day moving average is $13.42 and its 200 day moving average is $12.10.
Inovalon Holdings (NASDAQ:INOV) last posted its quarterly earnings data on Wednesday, May 3rd. The technology company reported $0.05 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.05. The business had revenue of $108.31 million during the quarter, compared to the consensus estimate of $102.05 million. Inovalon Holdings had a net margin of 6.51% and a return on equity of 6.34%. On average, analysts forecast that Inovalon Holdings will post $0.30 earnings per share for the current fiscal year.
A number of research analysts have issued reports on INOV shares. BidaskClub raised shares of Inovalon Holdings from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 10th. Zacks Investment Research raised shares of Inovalon Holdings from a “hold” rating to a “buy” rating and set a $13.00 target price for the company in a report on Wednesday, April 26th. Robert W. Baird reissued a “neutral” rating and set a $12.00 price objective (up from $11.00) on shares of Inovalon Holdings in a research note on Friday, June 16th. Finally, William Blair reissued a “market perform” rating on shares of Inovalon Holdings in a research note on Thursday, February 23rd. Three investment analysts have rated the stock with a sell rating, six have given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $15.11.
In other Inovalon Holdings news, insider Joseph R. Rostock sold 104,649 shares of the stock in a transaction on Monday, May 8th. The shares were sold at an average price of $13.07, for a total value of $1,367,762.43. Following the completion of the sale, the insider now directly owns 171,824 shares of the company’s stock, valued at approximately $2,245,739.68. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Keith R. Dunleavy purchased 40,000 shares of Inovalon Holdings stock in a transaction on Friday, May 5th. The stock was bought at an average cost of $12.98 per share, with a total value of $519,200.00. Following the completion of the acquisition, the chief executive officer now owns 220,000 shares in the company, valued at $2,855,600. The disclosure for this purchase can be found here. 48.28% of the stock is currently owned by corporate insiders.
About Inovalon Holdings
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.